Gene therapy trial tracks Long-Term safety for Radiation-Induced dry mouth
NCT ID NCT06544798
Summary
This study is following patients for up to five years to check the long-term safety and effectiveness of an experimental gene therapy for severe, persistent dry mouth. The therapy involves injecting a modified virus into the salivary glands to help them produce more saliva. It is specifically for people who developed this condition after radiation treatment for head or neck cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRADE 2 AND 3 LATE XEROSTOMIA CAUSED BY RADIOTHERAPY FOR CANCERS OF THE UPPER AERODIGESTIVE TRACT, EXCLUDING THE PAROTID GLANDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alleghany General Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
Atrium Health
Charlotte, North Carolina, 28209, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Erie County Medical Center
Buffalo, New York, 14215, United States
-
Miami Cancer Institute at Baptist Health South Florida
Miami, Florida, 33176, United States
-
Shirley and Jim Fielding Northeast Cancer Centre - Health Sciences North
Greater Sudbury, Ontario, P3E 5J1, Canada
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Missouri
Columbia, Missouri, 65212, United States
Conditions
Explore the condition pages connected to this study.